Phase 1b/2a Trial of the Superoxide Dismutase Mimetic GC4419 to Reduce Chemoradiotherapy-Induced Oral Mucositis in Patients With Oral Cavity or Oropharyngeal Carcinoma
Anderson, Carryn M., Sonis, Stephen T., Lee, Christopher M., Adkins, Douglas, Allen, Bryan G., Sun, Wenqing, Agarwala, Sanjiv S., Venigalla, Madhavi L., Chen, Yuhchyau, Zhen, Weining, Mould, Diane R., Holmlund, Jon T., Brill, Jeffrey M., Buatti, John M.
Published in International journal of radiation oncology, biology, physics (01.02.2018)
Published in International journal of radiation oncology, biology, physics (01.02.2018)
Get full text
Journal Article
Phase Ib trial of superoxide (SO) dismutase (SOD) mimetic GC4419 to reduce chemoradiotherapy (CRT)-induced oral mucositis (OM) in patients (pts) with oral cavity or oropharyngeal carcinoma (OCC)
Anderson, Carryn M., Allen, Bryan G., Sun, Wenqing, Agarwala, Sanjiv S., Lee, Christopher M., Venigalla, Madhavi L., Greenberg, Larisa, Adkins, Douglas, Chen, Yuhchyau, Zhen, Weining, Mould, Diane R., Holmlund, Jon, Brill, Jeffrey Mark, Sonis, Stephen T., Buatti, John Michael
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article